Clinical Trials · NCT04447859
16-week Flexible vs. 8-week Semaglutide Titration
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Enrollment
- 100
- Start date
- Feb 2020
- Locations
- 1 site, Israel
- Primary endpoint
- Gastrointestinal adverse events (GI-AEs)